RHON-KLINIKUM AG (0NQH) Stock Statistics & Valuation Metrics
Total Valuation
RHON-KLINIKUM AG has a market cap or net worth of EUR 963.91M. The enterprise value is EUR 889.42M.
- Market Cap
- EUR 963.91M
- Enterprise Value
- EUR 889.42M
Share Statistics
RHON-KLINIKUM AG has 66,962,470 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 66,962,470
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
RHON-KLINIKUM AG’s return on equity (ROE) is 0.03 and return on invested capital (ROIC) is 0.24%.
- Return on Equity (ROE)
- 0.03
- Return on Assets (ROA)
- 0.02
- Return on Invested Capital (ROIC)
- 0.24%
- Return on Capital Employed (ROCE)
- 0.00
- Revenue Per Employee
- 101.24K
- Profits Per Employee
- 1,802.877
- Employee Count
- 19,120
- Asset Turnover
- 1.06
- Inventory Turnover
- 43.57
Valuation Ratios
The current PE Ratio of RHON-KLINIKUM AG is 22.50. RHON-KLINIKUM AG’s PEG ratio is 1.58.
- PE Ratio
- 22.50
- PS Ratio
- 0.56
- PB Ratio
- 0.70
- Price to FCF
- 0.00
- Price to Operating Cash Flow
- 0.00
- PEG Ratio
- 1.58
Income Statement
In the last 12 months, RHON-KLINIKUM AG had revenue of 1.94B and earned 34.47M in profits. Earnings per share was 0.52.
- Revenue
- 1.94B
- Gross Profit
- 167.75M
- Operating Income
- 4.39M
- Pretax Income
- 44.95M
- Net Income
- 34.47M
- EBITDA
- 69.40M
- Earnings Per Share (EPS)
- 0.52
Cash Flow
In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0 billion.
- Operating Cash Flow
- 0
- Free Cash Flow
- 0
- Free Cash Flow per Share
- 0.00
Dividends & Yields
RHON-KLINIKUM AG pays an annual dividend of ―, resulting in a dividend yield of 1.44%
- Dividend Per Share
- ―
- Dividend Yield
- 1.44%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 0.00%
- Earnings Yield
- 4.53%
Stock Price Statistics
- Beta
- -0.23
- 52-Week Price Change
- 21.19%
- 50-Day Moving Average
- 14.45
- 200-Day Moving Average
- 13.27
- Relative Strength Index (RSI)
- 41.31
- Average Volume (3m)
- 615
Important Dates
RHON-KLINIKUM AG upcoming earnings date is Nov 05, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 06, 2026
- Next Earnings Date
- Nov 05, 2026
- Ex-Dividend Date
- ―
Financial Position
RHON-KLINIKUM AG as a current ratio of 2.60, with Debt / Equity ratio of 9.25%
- Current Ratio
- 2.60
- Quick Ratio
- 2.49
- Debt to Market Cap
- 0.14
- Net Debt to EBITDA
- -0.69
- Interest Coverage Ratio
- 1.46
Taxes
In the past 12 months, RHON-KLINIKUM AG has paid 8.67M in taxes.
- Income Tax
- 8.67M
- Effective Tax Rate
- 0.19
Enterprise Valuation
RHON-KLINIKUM AG EV to EBITDA ratio is 7.87, with an EV/FCF ratio of 0.00.
- EV to Sales
- 0.55
- EV to EBITDA
- 7.87
- EV to Free Cash Flow
- 0.00
- EV to Operating Cash Flow
- 0.00
Balance Sheet
RHON-KLINIKUM AG has EUR 556.55M in cash and marketable securities with EUR 121.88M in debt, giving a net cash position of EUR 434.67M billion.
- Cash & Marketable Securities
- EUR 556.55M
- Total Debt
- EUR 121.88M
- Net Cash
- EUR 434.67M
- Net Cash Per Share
- EUR 6.49
- Tangible Book Value Per Share
- EUR 18.35
Margins
Gross margin is -1.43%, with operating margin of 2.98%, and net profit margin of 2.43%.
- Gross Margin
- -1.43%
- Operating Margin
- 2.98%
- Pretax Margin
- 3.17%
- Net Profit Margin
- 2.43%
- EBITDA Margin
- 6.98%
- EBIT Margin
- 3.22%
Analyst Forecast
The average price target for RHON-KLINIKUM AG is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 4.91%
- EPS Growth Forecast
- 11.71%
Scores
- Smart Score
- 7
- AI Score
- ―